Search

everythinglearnresearchcommunity

for

Search:↓

Hataedock treatment improved skin health and reduced atopic dermatitis symptoms by enhancing the skin barrier and reducing inflammation.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

The cooling system effectively and safely treats benign pigmented lesions in Asians.

DA-9401 helps protect rat testis from finasteride damage.

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

A 44-year-old woman with Down's syndrome was diagnosed with both rheumatoid and gouty arthritis and treated with multiple medications.

Combining liposuction with laser ablation effectively reduces underarm odor with minimal side effects.

MSUD patients need careful monitoring of amino acids and zinc to prevent severe symptoms.

HS needs personalized treatment plans and more research.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

3D models and organoids improve liposarcoma research and therapy development.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

CT60 polymorphism might increase the risk of Alopecia Areata.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

SAHA syndrome links oily skin, acne, excess hair, and hair loss in women, similar to PCOS.

The hydrogel helps heal wounds and regrow hair by mimicking a baby's environment.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Solidified SEDDS improve drug stability and bioavailability better than liquid SEDDS.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

The ILDS Newsletter reported on efforts to support albinism patients in Tanzania and dermatological conferences.